Association between antihypertensive medication use and kidney cancer risk: a meta-analysis accounting for hypertension
- Published on 06/09/2025
- Reading time: 5 min.
Jung Minji 1, Li Mingyi 1,2, Shin Jaekyu 3, Chung Benjamin I. 1, Langston Marvin E. 2
1 https://ror.org/03mtd9a03 Department of Urology Stanford University Medical Center Stanford CA USA
2 https://ror.org/00f54p054 Department of Epidemiology and Population Health, School of Medicine Stanford University Stanford CA USA
3 https://ror.org/043mz5j54 Department of Clinical Pharmacy, School of Pharmacy University of California San Francisco CA USA
Abstract
Background Evidence that antihypertensive medication (AHTN) use is associated with an increased risk of kidney cancer (KC) is emerging. However, limited evidence is available on disentangling the effects of AHTN use on KC from hypertension, which is a risk factor for KC. We aimed to identify pooled estimates for the associations between AHTN use and KC risk, independent of hypertension.
Methods We searched for observational studies that investigated the...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Cardiology
Receive our newsletter to stay up to date with the latest news in Cardiology
